2020-10-29 OMA Agenda - Board of Trustees

Table 1 LOWER RISK for Telemedicine Prescribing Age: 18-64 years old Previously tolerated phentermine Few active medical conditions Normal vital signs documented in the past 6 months

HIGHER RISK for Telemedicine Prescribing Age: 65 or older Cardiac disease: hypertension, CHF, arrhythmia, CAD, valvular disease, pulmonary hypertension, previous cardiac surgeries or procedures Vertebrovascular disease: CVA, TIA, seizures, basilar migraines Diabetes Type 1 or 2 History of substance use disorder History of mood disorders History of restrictive eating disorders

Current use of medication with CNS or cardiovascular effect Current use of medication that can interact with phentermine Risk of pregnancy

References

1. Ann Intern Med. doi:10.7326/M20-3214 2. J Clin Endocrinol Metab, February 2015, 100(2):342–362 doi: 10.1210/jc.2014-3415 3. ACP’s Interactive Learning Module: Telemedicine: A Practical Guide for Incorporation Into Your Practice Release date 3/18/2020, accessed 8/7/2020 4. https://www.dea.gov/press-releases/2020/03/20/deas-response-covid-19 accessed 8/7/2020 5. “Safety and Effectiveness of Long-Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort 6. Obesity position statement

Note: Dr. Theresa Garcia is not a Diplomate of the American Board of Obesity Medicine but practices obesity medicine clinically